
Striving for Consensus on the Management of ALK-Positive Lung Cancer
Lung Cancer Update
00:00
The Pro and Cons of Law Latinib in Breast Cancer
Ross: I gave a strong argument against more latinib as the first line therapy but let's unpack some of the stuff that we we know and we don't know so all that there was a pretty amazing drug it has very good CNS penetration and it has this amazing results from crown. Ross: The most dramatic CNS efficacy of law latinib is in protecting the CNS that flat line is for people who don't have baseline brain metastases whereas if you look at the people who do have baseline brain metastases it still comes down. He says he'd also raise the idea that this may not just be because it's an alkinhibitor that gets into the brain
Transcript
Play full episode